AMARILLO, TX--(Marketwire - January 14, 2008) - Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that the Company’s public policy efforts helped attract a $526,000 grant to the Texas Tech University System for the creation of the West Texas Influenza Research Center to study influenza treatments, including the use of oral interferon as a preventative and therapeutic agent.
